Literature DB >> 17382256

HLA-DR15, reduced relapse rate and improved survival after HLA identical sibling hemopoietic stem cell transplantation.

J A Davidson, D G Tate, K V Poulton, G S Lucas, J L Yin, E F Liakopoulou, R Wynn.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17382256     DOI: 10.1016/j.bbmt.2006.12.442

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  4 in total

Review 1.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

2.  HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.

Authors:  Minoo Battiwalla; Tao Wang; Jeanette Carreras; H Joachim Deeg; Mouhab Ayas; Rajinder P S Bajwa; Biju George; Vikas Gupta; Ricardo Pasquini; Hubert Schrezenmeier; Jakob R Passweg; Kirk R Schultz; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-28       Impact factor: 5.742

3.  Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous leukemia, independent of the presence of HLA-DR15.

Authors:  Laura F Newell; Ted Gooley; John A Hansen; Derek L Stirewalt; Effie W Petersdorf; H Joachim Deeg
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-09       Impact factor: 5.742

4.  HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

Authors:  Minoo Battiwalla; Kristin Ellis; Peigang Li; Steven Z Pavletic; Gorgun Akpek; Peiman Hematti; Thomas R Klumpp; Richard T Maziarz; Bipin N Savani; Mahmoud D Aljurf; Mitchell S Cairo; William R Drobyski; Biju George; Theresa Hahn; Nandita Khera; Mark R Litzow; Alison W Loren; Wael Saber; Mukta Arora; Alvaro Urbano-Ispizua; Corey Cutler; Mary E D Flowers; Stephen R Spellman
Journal:  Biol Blood Marrow Transplant       Date:  2012-03-10       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.